Effect of biphasic insulin aspart 30 [insulin aspart/insulin protamine aspart] combined with metformin on blood glucose control in subjects with type 2 diabetes inadequately controlled with basal insulin.
Phase of Trial: Phase IV
Latest Information Update: 03 Apr 2016
At a glance
- Drugs Insulin aspart/insulin protamine aspart (Primary) ; Metformin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Sponsors Novo Nordisk
- 31 Aug 2018 Biomarkers information updated
- 01 May 2009 Actual patient number (293) added as reported by ClinicalTrials.gov.
- 01 May 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.